Plain-English translation of NCT06099912 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →This study is testing a new approach called dynamic frailty-tailored therapy for older adults with newly diagnosed multiple myeloma. Instead of giving all patients the same treatment plan, doctors will assess how physically fit you are at the start and then adjust your treatment throughout your care based on how your fitness changes. The goal is to find the right balance between fighting the cancer effectively and keeping side effects manageable.
Older patients with multiple myeloma vary widely in their physical strength and ability to tolerate intensive treatments. Some patients are very frail and struggle with harsh side effects, while others are quite fit and can handle more intensive therapy. Currently, doctors typically check fitness only once at diagnosis, but research shows that fitness changes over time as patients age and undergo treatment. This trial exists to see whether checking and adjusting treatment based on fitness throughout the treatment course—rather than just at the beginning—leads to better outcomes.
You likely qualify if…
You likely don't qualify if…
You will receive personalized cancer treatment designed based on your current fitness level and how it changes over time during your care. Your doctors will regularly assess your physical fitness and adjust your treatment plan accordingly to optimize both effectiveness and safety. You will need to attend multiple clinic visits for treatment, monitoring, and fitness assessments throughout the study period, though the exact schedule is not yet specified in the trial details.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Sponsor
FengYan Jin
Collaborators
Sun Yat-Sen University Cancer Center, Ruijin Hospital
Enrollment target
~131 participants
Started
September 2021
Primary completion
September 2026
Age range
65 Years and older
Last updated on clinicaltrials.gov in February 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.